Unitaid reports that Dr. Reddy’s has received FDA tentative approval for generic injectable lenacapavir, used for twice-yearly HIV prevention. An existing agreement sets a medicine price of US$40 per person per year for 120 eligible low- and middle-income countries.

Tentative approval is a specific regulatory category, not permission to market the generic in the United States. The FDA uses it for medicines that meet approval requirements but face patent or exclusivity restrictions.

Unitaid expects initial supplies by the end of 2026 and wider availability in 2027. Those are projections, not completed deliveries. National approvals, funding and health systems able to provide the medicine still matter. The encouraging development is a cheaper option moving closer to use.

Source published November 2, 2026.

On November 1, viewers watching Royal Cam at Pukekura/Taiaroa Head saw a northern royal albatross lay an egg. New Zealand’s Department of Conservation says this was the first time its viewers had witnessed the laying live.

The female, known as L, and her mate are sharing incubation duties. Rangers expect roughly 79 days of sitting and planned to check fertility after 10 to 12 days. An egg is a hopeful beginning, not a confirmed chick.

The previous breeding season ended with a record-equal 38 chicks fledging from the colony. That is a local achievement, not proof that the species is secure. For now, this season’s drama involves patience, careful conservation work and one very small leading role.

Source published November 4, 2026.